Infections continue to threaten the longevity and well-being of Ethiopians. The Addis Ababa University (AAU) and McGill Partnership for Infectious Diseases (AMP-ID) was formally launched in 2017 to foster and promote training and research in Infectious and Tropical Diseases. This partnership builds on the historical collaboration between AAU and McGill, which led to the creation of the Department of Medicine and the School of Public Health at AAU (in the 1980s) and on the joint Postgraduate Fellowship Training Program in Infectious Diseases launched in 2009.
LATEST NEWS
AMP-ID has launched the latest of its research projects aiming towards improved antimicrobial stewardship in 2022. The study entitled "Impact of mobile clinical decision support tool on prescription behaviour and patient outcomes in low-resource ...Read more
AMP-ID has launched the latest of its research projects aiming towards improved antimicrobial stewardship in 2022. The study entitled "Impact of mobile clinical decision support tool on prescription behaviour and patient outcomes in low-resource settings: A pilot trial of self-stewardship in Ethiopia" was launched at two study sites, two of the largest public teaching hospitals in Ethiopia: the Tikur Anbessa specialized hospital (affiliated with Addis Ababa University) and St. Paul's Hospital Millennium Medical College. The study's aims are to assess the impact of a bundle of interventions consisting of a basic bacteriology laboratory support and an electronic decision support tool designed to promote active learning, on physician prescription behaviour (quality of prescriptions) and patient outcomes in the study sites. The study is sponsored by the McGill Interdisciplinary Initiative for Infection and Immunity (MI4)
Advance knowledge that will improve the quality of care of patients afflicted with infectious diseases, through interdisciplinary and international collaborations; promote translation of that knowledge into policy and practice.
